Johnson & Johnson - 63 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1962 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of July 08, 2025 is 155.79.
  • The all-time high Johnson & Johnson stock closing price was 168.80 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 169.99, which is 9.1% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 140.68, which is 9.7% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 156.39.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 153.7965 141.6640 166.2770 139.7360 155.7900 9.51%
2024 150.5325 152.5250 163.3320 138.7730 142.2550 -4.81%
2023 150.4521 164.8930 166.7990 137.7210 149.4450 -8.58%
2022 157.5496 154.6750 168.7990 143.5080 163.4680 5.98%
2021 147.3126 137.6450 159.8230 135.4680 154.2510 11.44%
2020 126.4814 124.9860 138.4190 95.7697 138.4190 10.82%
2019 113.8616 106.3860 125.3880 104.6960 124.9000 16.22%
2018 109.2594 112.8840 123.1170 98.1493 107.4690 -5.13%
2017 103.8781 91.5419 115.8520 88.3177 113.2820 24.43%
2016 88.5700 77.2213 97.7644 73.5862 91.0441 15.33%
2015 75.5193 78.0140 80.8871 69.2179 78.9428 1.14%
2014 74.2524 66.1120 80.9996 62.9092 78.0513 17.34%
2013 61.3912 49.9322 69.4528 49.8617 66.5187 34.62%
2012 46.3230 44.7793 50.6683 42.7758 49.4106 10.85%
2011 42.4021 41.2000 45.3374 38.1578 44.5753 9.89%
2010 40.0204 40.9743 42.1496 36.7306 40.5638 -0.59%
2009 36.0280 37.1734 41.1517 28.7988 40.8033 11.27%
2008 39.1830 39.2668 43.9000 33.9127 36.6708 -7.72%
2007 37.6180 38.5730 40.7503 35.0580 39.7375 3.61%
2006 35.7181 34.9791 39.9160 32.2377 38.3522 12.43%
2005 36.3430 35.0076 38.7924 34.0766 34.1107 -3.36%
2004 30.8179 28.1986 35.4862 27.1387 35.2970 25.17%
2003 28.4442 29.6648 31.5850 26.4724 28.1986 -2.08%
2002 30.6850 31.0477 34.7467 22.2796 28.7962 -7.88%
2001 27.2986 26.6207 32.2484 21.8001 31.2593 14.00%
2000 23.1445 23.7270 27.4200 17.6939 27.4200 14.25%
1999 24.0719 21.0362 27.3142 19.5893 24.0005 12.48%
1998 18.9717 16.3398 22.6421 16.0729 21.3383 28.98%
1997 14.8743 12.3191 16.8106 12.3191 16.5438 34.29%
1996 11.9386 10.2783 13.3096 10.2173 12.3191 18.10%
1995 8.3300 6.5252 11.1628 6.4354 10.4308 59.12%
1994 5.4724 5.2858 6.6450 4.3192 6.5552 25.05%
1993 4.8463 5.6443 5.6443 4.1364 5.2420 -8.97%
1992 5.5772 6.2856 6.5166 4.8715 5.7583 -10.19%
1991 4.9805 3.8538 6.4676 3.6129 6.4116 62.31%
1990 3.4260 3.2279 3.9986 2.8033 3.9501 23.41%
1989 2.6950 2.2487 3.2009 2.2487 3.2009 39.84%
1988 2.1756 2.0976 2.3688 1.8674 2.2890 13.86%
1987 2.3127 1.8068 2.8081 1.7312 2.0103 14.23%
1986 1.7076 1.3893 1.9805 1.2788 1.7599 24.87%
1985 1.1918 0.9524 1.4663 0.9390 1.4094 45.93%
1984 0.9157 1.0904 1.1304 0.7544 0.9658 -11.43%
1983 1.2173 1.3186 1.3619 1.0471 1.0904 -17.51%
1982 1.0873 0.9742 1.3586 0.8648 1.3219 33.86%
1981 0.9079 0.8843 1.0232 0.7578 0.9875 11.81%
1980 0.7025 0.6792 0.8854 0.5886 0.8832 25.94%
1979 0.6379 0.6567 0.7080 0.5729 0.7013 7.51%
1978 0.6786 0.6630 0.7848 0.5824 0.6523 -3.86%
1977 0.6218 0.6904 0.6904 0.5535 0.6785 -1.55%
1976 0.7628 0.7962 0.8492 0.6362 0.6892 -13.08%
1975 0.7859 0.7331 0.8745 0.6514 0.7929 11.00%
1974 0.8705 0.9869 1.0499 0.6635 0.7143 -28.26%
1973 1.0497 1.1347 1.1524 0.9228 0.9957 -13.60%
1972 1.0413 0.8631 1.1667 0.8377 1.1524 32.51%
1971 0.7515 0.5054 0.8730 0.5054 0.8697 72.83%
1970 0.4542 0.5164 0.5231 0.3299 0.5032 -5.00%
1969 0.3761 0.3112 0.5297 0.2979 0.5297 69.02%
1968 0.2603 0.2648 0.3134 0.2200 0.3134 16.07%
1967 0.2253 0.1658 0.2817 0.1628 0.2700 61.00%
1966 0.1704 0.1717 0.1962 0.1372 0.1677 -0.71%
1965 0.1361 0.1091 0.1711 0.1091 0.1689 54.11%
1964 0.1030 0.1024 0.1167 0.0942 0.1096 9.60%
1963 0.0881 0.0733 0.1164 0.0728 0.1000 39.08%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $373.591B $88.821B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $732.476B 56.17
AbbVie (ABBV) United States $331.430B 18.27
Novo Nordisk (NVO) Denmark $309.514B 20.51
Novartis AG (NVS) Switzerland $257.969B 14.73
Roche Holding AG (RHHBY) Switzerland $257.158B 0.00
Merck (MRK) United States $203.142B 10.39
Pfizer (PFE) United States $143.499B 7.86
Sanofi (SNY) France $118.503B 11.67
Bayer (BAYRY) Germany $30.023B 6.11
Innoviva (INVA) United States $1.187B 12.44